For instance: people with obesity are more likely to develop type 2 diabetes people with obesity are at an increased riskof developing Alzheimers later in life people with type 2 diabetes are also more likely to develop Alzheimers disease Alzheimers disease is associated with insulin resistance in the brain, with some scientists referring to Alzheimers as type 3 diabetes obesity, type 2 diabetes, and Alzheimers all involve inflammation, and GLP-1 agonists have an anti-inflammatory effect studies in animal models of dementiahave shown that GLP-1 agonists can protect rats brains from damage
Ramazani Z, Nakhaee S, Sharafi K, Rezaei Z, Mansouri B (2024) Autism spectrum disorder: cadmium and mercury concentrations in different biological samples, a systematic literature review and meta-analysis of human studies
GHK-Cu is a signal peptide
Gastrointestinal Side Effects: The Frequent Flier GI issues are the most commonly reported side effects of GLP-1 medicationsand theyre not subtle
Additionally, co-administration of this antagonist with a GLP-1 receptor agonist in DIO mice potentiated weight loss compared to either monotherapy (86)